CID 3064759

Ergoline, 8-((2-ethyl-1h-imidazol-1-yl)methyl)-6-methyl-, (8-beta)-

Structural Information

Molecular Formula
C21H26N4
SMILES
CCC1=NC=CN1C[C@@H]2CC3[C@@H](CC4=CNC5=CC=CC3=C45)N(C2)C
InChI
InChI=1S/C21H26N4/c1-3-20-22-7-8-25(20)13-14-9-17-16-5-4-6-18-21(16)15(11-23-18)10-19(17)24(2)12-14/h4-8,11,14,17,19,23H,3,9-10,12-13H2,1-2H3/t14-,17?,19-/m1/s1
InChIKey
MTKJHNAAXUYMMC-LJMFKLJISA-N
Compound name
(6aR,9R)-9-[(2-ethylimidazol-1-yl)methyl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

334.21576 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 335.22304 184.3
[M+Na]+ 357.20498 192.5
[M-H]- 333.20848 186.5
[M+NH4]+ 352.24958 199.0
[M+K]+ 373.17892 184.4
[M+H-H2O]+ 317.21302 174.0
[M+HCOO]- 379.21396 195.9
[M+CH3COO]- 393.22961 192.9
[M+Na-2H]- 355.19043 183.5
[M]+ 334.21521 183.3
[M]- 334.21631 183.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe